Androgen Receptor
AR (androgen receptor) is a member of steroid hormone receptor and ligand-activated transcription factor. It plays a crucial role in prostate cellular proliferation and male sexual differentiation.
Products Related to Androgen Receptor(159)
- GC10618FluoxymesteroneCAS: 76-43-7Purity: >98%
Fluoxymesterone is a synthetic androgen drug that decomposes slowly in the body and has a long-lasting effect.
- GC11070Dehydroepiandrosterone (DHEA)CAS: 53-43-0Purity: >98.00%
Dehydroepiandrosterone (DHEA) and its sulfate ester, DHEAS, together represent the most abundant steroid hormones in the human body .
- GC12271BicalutamideCAS: 90357-06-5Purity: >98.00%
Bicalutamide is a non-steroidal antiandrogen that selectively and competitively blocks androgen binding to the androgen receptor (AR), exerting anti-androgenic effects in peripheral tissues.
- GC12385MDV3100 (Enzalutamide)CAS: 915087-33-1Purity: >99.50%
MDV3100 (Enzalutamide) is an oral inhibitor of androgen receptor (AR) with an IC 50 value of 36nM.
- GC127913,3'-DiindolylmethaneCAS: 1968-05-4Purity: >98.00%
A phytochemical with antiradiation and chemopreventative effects
- GC12974Medroxyprogesterone acetateCAS: 71-58-9Purity: >99.50%
Medroxyprogesterone acetate (MPA) is a synthetic progestin.
- GC157745α-dihydro-11-keto TestosteroneCAS: 32694-37-4Purity: >98.00%
5α-dihydro-11-keto Testosterone (11-KDHT; 5α-Dihydro-11-keto testosterone) is an endogenous steroid and a metabolite of 11β-Hydroxyandrostenedione.
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC13362 | TOK-001 | 851983-85-2 | >99.50% | |
TOK-001 (TOK-001) is a multifunctional antiandrogen and CYP17 inhibitor (IC50=47 nM) in castration resistant prostate cancer (CRPC). | ||||
| GC13971 | Cyproterone Acetate | 427-51-0 | >98.00% | |
Androgen receptor antagonist | ||||
| GC27918 | LX1 | 2647877-84-5 | >99.00% | |
LX1 is an anti-prostate cancer compound that targets androgen receptor (AR), AR variants and steroidogenic enzyme AKR1C3. | ||||
| GC10372 | AZD3514 | 1240299-33-5 | >99.00% | |
Androgen receptor downregulator | ||||
| GC10547 | ASC-J9 | 52328-98-0 | >98.00% | |
A selective enhancer of AR degradation | ||||
| GC10567 | TCPOBOP | 76150-91-9 | >98.00% | |
TCPOBOP is a constitutive androgen receptor (CAR) agonist (EC 50 =0.05μM) that induces hepatocyte proliferation and hepatomegaly in mice without causing liver damage. | ||||
| GC10618 | Fluoxymesterone | 76-43-7 | >98% | |
Fluoxymesterone is a synthetic androgen drug that decomposes slowly in the body and has a long-lasting effect. | ||||
| GC10785 | Danazol | 17230-88-5 | >98.00% | |
Danazol is a synthetic anabolic steroid with properties of inhibition of interleukin-1 and TNF-α production. | ||||
| GC11070 | Dehydroepiandrosterone (DHEA) | 53-43-0 | >98.00% | |
Dehydroepiandrosterone (DHEA) and its sulfate ester, DHEAS, together represent the most abundant steroid hormones in the human body . | ||||
| GC11386 | ODM-201 | 1297538-32-9 | >99.00% | |
ODM-201 is a potent antagonist of the androgen receptor (AR) with a Ki value of 11nM and an IC 50 value of 26nM. | ||||
| GC11837 | MI-136 | 1628316-74-4 | >98.50% | |
menin-MLL interaction inhibitor | ||||
| GC11957 | RD162 | 915087-27-3 | >98% | |
androgen receptor (AR) antagonist | ||||
| GC12271 | Bicalutamide | 90357-06-5 | >98.00% | |
Bicalutamide is a non-steroidal antiandrogen that selectively and competitively blocks androgen binding to the androgen receptor (AR), exerting anti-androgenic effects in peripheral tissues. | ||||
| GC12385 | MDV3100 (Enzalutamide) | 915087-33-1 | >99.50% | |
MDV3100 (Enzalutamide) is an oral inhibitor of androgen receptor (AR) with an IC 50 value of 36nM. | ||||
| GC12445 | TFM-4AS-1 | 188589-61-9 | >98% | |
androgen receptor modulator | ||||
| GC12791 | 3,3'-Diindolylmethane | 1968-05-4 | >98.00% | |
A phytochemical with antiradiation and chemopreventative effects | ||||
| GC12933 | RU 58841 | 154992-24-2 | >99.50% | |
A non-steroidal antiandrogen | ||||
| GC12938 | PF 998425 | 1076225-27-8 | >98.00% | |
non-steroidal androgen receptor (AR) antagonist | ||||
| GC12974 | Medroxyprogesterone acetate | 71-58-9 | >99.50% | |
Medroxyprogesterone acetate (MPA) is a synthetic progestin. | ||||
| GC13685 | Andarine | 401900-40-1 | >99.50% | |
Andarine (S-4) is an orally active and selective nonsteroidal androgen receptor (AR) modulator (SARM) and a partial agonist, with Ki of 4 nM. Andarine (S-4) is identified as SARMs with potent and tissue-selective in vivo pharmacological activity. | ||||
| GC14221 | HE-3235 | 183387-50-0 | >98% | |
HE-3235, synthetic analogue of 3β-androstanediol, is an orally bioavailable anticancer agent. HE-3235 is active in rodent models of prostate and breast cancer. | ||||
| GC14560 | Cl-4AS-1 | 188589-66-4 | >98% | |
steroidal androgen receptor agonist | ||||
| GC15774 | 5α-dihydro-11-keto Testosterone | 32694-37-4 | >98.00% | |
5α-dihydro-11-keto Testosterone (11-KDHT; 5α-Dihydro-11-keto testosterone) is an endogenous steroid and a metabolite of 11β-Hydroxyandrostenedione. | ||||
| GC16631 | EPI-001 | 227947-06-0 | >98.00% | |
AR antagonist | ||||
